CBC Group (formerly C-Bridge Capital) is a healthcare-dedicated investment firm focused on early, middle & late-stage growth and buyout investment opportunities including the pharmaceutical/ biotech, medical technology and healthcare services sub-sectors.Established in 2014 with the entrepreneurial vision and drive to build, grow and transform healthcare businesses across Asia, CBC Group is one of the largest and most active healthcare-dedicated investment firms in Asia, with offices in Singapore, Shanghai, New York, Beijing and Hong Kong.

Focusing on healthcare and life science early and growth stage investment.

Healthcare industry investment professional.

※ Kaiwu Capital is a venture capital firm focuses on broad sectors including Technology, Media & Telecom (TMT), Healthcare, Clean-tech and Consumption Upgrade. Members of the investment team are seasoned investors who have had extensive investment, operational and entrepreneurial experience in China.※ Extensively involved in deals mainly focused on Healthcare sector: advanced intermediate/CMO sector; dialysis services; prenatal diagnosis; genomics scientific; endoscopic surgical; cardiovascular stents;※ Involved in other selected deals which covered sectors of healthcare as: Generic and Biosimilar Drugs, Molecular Diagnostics, Chronic Disease, Digital Healthcare, Medical Consumables and Devices, Orthopedics Products, Coronary Stent and Balloon Catheter, etc.※ Industry Research: Digital Healthcare; Food Inspection and Testing.

※ Visiting scholar in the collaborative bioengineering research program between CAMS&PUMC and University of California San Diego, USA. - Conducted research in artificial pancreas biosensor and analyzed market for diabetes treatment.※ Delegate to the Ninth World Congress for Microcirculation, poster presentation.